A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.	Platinum-resistant Recurrent Ovarian Cancer	Recruiting	Phase 2	2026-05-05		NCT06434610

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Jiaolian Drug Research and Development Co., Ltd	6
Shanghai Pharmaceuticals Holding Co., Ltd	20

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Cancer Hospital	Beijing	China	85
Cancer Hospital of Shandong First Medical University	Jinan	China	12
Fudan University Shanghai Cancer Center	Shanghai	China	128
Fujian Cancer Hospital	Fuzhou	China	37
Guangxi Medical University Cancer Hospital	Nanning	China	17
Henan Cancer Hospital	Zhengzhou	China	60
QiLu Hospital of ShanDong University	Jinan	China	21
Shananxi Provincial Cancer Hospital	Xi'an	China	1
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou	China	24
The First Affiliated Hospital of Bengbu Medical University	Bengbu	China	14
The First Affiliated Hospital of Xiamen University	Xiamen	China	40
The Obstetrics & Gynecology Hospital of Fudan University	Shanghai	China	3
The Second Hospital of Hebei Medical University	Shijiazhuang	China	9
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	37
XiangYa Hospital CentralSouth University	Changsha	China	3
Yibin city second people's Hospital	Yibin	China	1
Yunnan Cancer Hospital	Kunming	China	22